Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT00057382
What this trial is testing

T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients

Who this might be right for
Hepatocellular Carcinoma
Tularik 750
Early research (Phase 1)Ended earlyNCT05427396
What this trial is testing

A Phase I Clinical Study of Recombinant Humanized Anti-BTLA Monoclonal Antibody (JS004) Injection Combined With Toripalimab Injection in Patients With Advanced Solid Tumors

Who this might be right for
Liver Cancer, Esophageal Squamous Cell Carcinoma, Gastric Adenocarcinoma, Cervical Cancer, MSI-H Colorectal Cancer
Shanghai Junshi Bioscience Co., Ltd. 31
Testing effectiveness (Phase 2)Study completedNCT02040142
What this trial is testing

HIPEC for Peritoneal Carcinomatosis

Who this might be right for
Peritoneal CarcinomatosisColorectal CancerAppendiceal Cancer+3 more
Albert Einstein College of Medicine 51
Not applicableStudy completedNCT05126173
What this trial is testing

DERM US and EU Validation Study

Who this might be right for
Malignant Skin Melanoma T0Basal Cell CarcinomaSquamous Cell Carcinoma
Skin Analytics Limited 1,111
Not applicableLooking for participantsNCT06061705
What this trial is testing

Identification of Individual Histological and Blood Markers in Patients With Recurrent or Metastatic Upper Aerodigestive Tract Squamous Cell Carcinoma in Response to Immunotherapies

Who this might be right for
Squamous Cell Carcinoma of the Oropharynx
Fondation Hôpital Saint-Joseph 100
Not applicableUnknownNCT00192829
What this trial is testing

Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma

Who this might be right for
Non-Small Cell Lung CarcinomaVenous Thromboembolism
Rambam Health Care Campus 100
Early research (Phase 1)Not Yet RecruitingNCT07770802
What this trial is testing

Clinical Study of HS-IT101 Injection in the Treatment of Advanced Renal Cancer

Who this might be right for
Clear Cell Renal Cell Carcinoma
Qingdao Sino-Cell Biomedicine Co., Ltd. 15
Large-scale testing (Phase 3)Active Not RecruitingNCT03873402
What this trial is testing

Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Participants With Advanced Kidney Cancer

Who this might be right for
Renal Cell Carcinoma
Bristol-Myers Squibb 437
Large-scale testing (Phase 3)Study completedNCT01282437
What this trial is testing

Prophylactic Cranial Irradiation (PCI) vs Observation in Stage III NSCLC

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)Radical TreatmentStage III Non-Small Cell Lung Cancer
Maastricht Radiation Oncology 315
Not applicableNot Yet RecruitingNCT06780553
What this trial is testing

Validation of the Proteomic Profiling as a Diagnostic Test for Extra-hepatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
University Hospital, Bordeaux 60
Very early researchStudy completedNCT04028245
What this trial is testing

Combination Spartalizumab and Canakinumab in Patients With Localized Clear Cell Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Columbia University 17
Testing effectiveness (Phase 2)Study completedNCT00815295
What this trial is testing

Study of Sorafenib/Cetuximab in Head and Neck Cancer

Who this might be right for
Squamous Cell Cancer
Duke University 31
Testing effectiveness (Phase 2)UnknownNCT03732495
What this trial is testing

Study of the Efficacy of Lenvatinib Combined With Denosumab in the Treatment of Patients With Predominant Bone Metastatic Radioiodine Refractory Differentiated Thyroid Carcinomas

Who this might be right for
Thyroid Cancer Metastatic
Centre Leon Berard 35
Testing effectiveness (Phase 2)Study completedNCT00103831
What this trial is testing

Oral Taxane in Combination With Pemetrexed (Alimta) in Patients With Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Bristol-Myers Squibb
Large-scale testing (Phase 3)Ended earlyNCT01419002
What this trial is testing

Study to Evaluate if Neoadjuvant Radiotherapy Improves Recurrence Free Survival in Pancreatic Head Cancer

Who this might be right for
Pancreatic Adenocarcinoma
CHIR-Net 5
Early research (Phase 1)UnknownNCT04142931
What this trial is testing

Sequentional Immuno Apheresis Plasma Volume Escalation Cohort Study of Reduction of Soluble Tumor Necrosis Factor Receptors 1 and 2 (sTNFR1/2) With or Without Nivolumab in Patients With Inoperable or Metastatic Solid Tumors

Who this might be right for
Stage IV Non-small Cell Lung CancerStage IV MelanomaTriple Negative Breast Cancer+1 more
Dr. Ronnie Shapira 30
Testing effectiveness (Phase 2)Study completedNCT03472053
What this trial is testing

BIO-11006 in the Treatment of Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer Stage IIIB
BioMarck Pharmaceuticals, Ltd. 60
Testing effectiveness (Phase 2)UnknownNCT00637637
What this trial is testing

External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases

Who this might be right for
Cancer
Oncology Institute of Southern Switzerland 60
Large-scale testing (Phase 3)Active Not RecruitingNCT04211337
What this trial is testing

Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer

Who this might be right for
Medullary Thyroid Cancer
Loxo Oncology, Inc. 291
Not applicableLooking for participantsNCT05629845
What this trial is testing

Prevention of Variceal Rebleeding by EUS-guided vs Conventional Endoscopic Therapy in Hepatocellular Carcinoma Patients

Who this might be right for
Hepatocellular CarcinomaVariceal Bleeding
Chinese University of Hong Kong 84
Next Page